Bright Rock Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,000
Closed -$1.43M 71
2023
Q3
$1.43M Hold
9,000
0.35% 65
2023
Q2
$1.27M Hold
9,000
0.3% 73
2023
Q1
$1.52M Hold
9,000
0.38% 70
2022
Q4
$1.52M Hold
9,000
0.4% 66
2022
Q3
$1.68M Hold
9,000
0.47% 64
2022
Q2
$1.46M Buy
+9,000
New +$1.42M 0.39% 69

Other funds holding RGEN

Bright Rock Capital Management's RGEN Position: Q4 2023 in Review

Bright Rock Capital Management sold out of Repligen (RGEN) in Q4 2023, closing a stake of 9,000 shares — an estimated $1.43M sold.

Bright Rock Capital Management first reported a position in RGEN in Q2 2022 and held it in 6 quarters. The position peaked at $1.68M in Q3 2022. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • Bright Rock Capital Management reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • Bright Rock Capital Management sold 9,000 Repligen shares in Q4 2023, an estimated $1.43M.
  • Bright Rock Capital Management first reported a position in Repligen in Q2 2022 and held it in 6 quarters.
  • Bright Rock Capital Management's Repligen position peaked at $1.68M in Q3 2022.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on Bright Rock Capital Management's 13F filing for Q4 2023, filed 11 Jan 2024.